Allogene Therapeutics Statistics

Total Valuation

ALLO has a market cap or net worth of $286.54 million. The enterprise value is $94.32 million.

Market Cap	286.54M
Enterprise Value	94.32M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ALLO has 218.73 million shares outstanding. The number of shares has increased by 26.55% in one year.

Current Share Class	218.73M
Shares Outstanding	218.73M
Shares Change (YoY)	+26.55%
Shares Change (QoQ)	+2.27%
Owned by Insiders (%)	9.29%
Owned by Institutions (%)	72.39%
Float	156.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.77
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.23.

Current Ratio	9.71
Quick Ratio	9.40
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-764.86

Financial Efficiency

Return on equity (ROE) is -59.60% and return on invested capital (ROIC) is -30.68%.

Return on Equity (ROE)	-59.60%
Return on Assets (ROA)	-28.92%
Return on Invested Capital (ROIC)	-30.68%
Return on Capital Employed (ROCE)	-52.97%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	229
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ALLO has paid $443,000 in taxes.

Income Tax	443,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.21% in the last 52 weeks. The beta is 0.60, so ALLO's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-47.21%
50-Day Moving Average	1.36
200-Day Moving Average	2.07
Relative Strength Index (RSI)	54.44
Average Volume (20 Days)	3,975,346

Short Selling Information

The latest short interest is 27.36 million, so 12.51% of the outstanding shares have been sold short.

Short Interest	27.36M
Short Previous Month	30.13M
Short % of Shares Out	12.51%
Short % of Float	17.48%
Short Ratio (days to cover)	7.21

Income Statement

Revenue	n/a
Gross Profit	-190.24M
Operating Income	-253.17M
Pretax Income	-251.88M
Net Income	-252.32M
EBITDA	-239.99M
EBIT	-253.17M
Earnings Per Share (EPS)	-$1.22

Full Income Statement

Balance Sheet

The company has $280.04 million in cash and $88.92 million in debt, giving a net cash position of $191.12 million or $0.87 per share.

Cash & Cash Equivalents	280.04M
Total Debt	88.92M
Net Cash	191.12M
Net Cash Per Share	$0.87
Equity (Book Value)	385.39M
Book Value Per Share	1.76
Working Capital	261.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$197.33 million and capital expenditures -$785,000, giving a free cash flow of -$198.12 million.

Operating Cash Flow	-197.33M
Capital Expenditures	-785,000
Free Cash Flow	-198.12M
FCF Per Share	-$0.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.55%
Shareholder Yield	-26.55%
Earnings Yield	-88.40%
FCF Yield	-69.41%

Analyst Forecast

The average price target for ALLO is $8.44, which is 544.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.44
Price Target Difference	544.28%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	649.78%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALLO has an Altman Z-Score of -3.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.72
Piotroski F-Score	1